FEMSelect is a Woman-Led Company

As co-CEOs of FEMSelect, Debbie and Renee both have a deep understanding of the debilitating symptoms and emotional strains caused by prolapse. Over their careers, both have been committed to women’s health and are leading together to develop innovative and safe solutions for women.

Debbie Garner

Co-CEO

Debbie has 20 years of experience in commercialization leadership roles. She has launched and built the market for innovative women’s health care products with Eli Lilly and Co. and iMDsoft in numerous international markets. Debbie holds an MBA from the Wharton School of Business of the University of Pennsylvania and a BA from Harvard College.

Renee Selman

Co-CEO

Renee brings 25+ years of pharma, medical device & digital health senior management experience. She is former Global President with Ethicon, Women’s Health & Urology where she led an organizational turnaround growing sales 45%, improving net income and growing key emerging markets by more than 20% through market development.

Joel Chechik

Chief Commercial Officer

Joel brings 20+ years of Sales and Marketing leadership to FEMSelect, having served in sales leadership roles with Coloplast, Medtronic and NeoTract. He has led targeted marketing and sales expansion initiatives driving adoption of minimally invasive, cardiac and urologic implantable technologies. Joel is a hands-on US-based sales leader who can show a sales team how to work with key opinion leader physicians who need to learn and become confident with a new procedure, before recommending that procedure to patients and to colleagues in their practice and medical center.

Karla Loken DO ObGyn FACOOG

Chief Medical Officer US

Dr Loken brings years of experience in Medical Affairs for several global therapeutics and medical device companies as well as 20+ years of women’s health experience in private practice, medical education and academics – which have prepared her to drive adoption of this innovative new approach to treating Pelvic Organ Prolapse.

Prof. Menahem Neuman

Founder & Medical Director

Menahem is currently Head of Urogynecology, Galilee Medical Center and Bar-Ilan University. Prior to this, he was Ethicon Women’s Health & Urology PFR global trainer and Pelvic Floor Innovation Committee Member.

Boaz Harari

Founder VP Research & Development

Boaz has over 20 years of experience in the medical device field. Former CTO of VibeMedic Ltd. and Niti Surgical Solutions Ltd. He is an experienced engineer who has developed numerous clinical devices from concept to market.

Sherwyn Davidson

VP Quality and Regulatory Affairs

Sherwyn is an experienced medical device Quality Management and Regulatory professional. He has over 20 years of experience interacting with regulatory authorities and establishing and maintaining a Quality Management System with more than 10 years as Senior Project Manager at Medicsense Ltd., a leading Israeli consulting firm. Sherwyn holds a B.Sc. in Industrial Engineering from Ben-Gurion University.

EnPlace® Development Timeline

2012-14

POP Medical Solutions Ltd. founded. First in Woman clinical study begins.

2016

EnPlace receives 510(k) clearance.

2018

EnPlace Post-Marketing Clinical Study Kickoff.
CE Mark obtained.

2020

EnPlace Commercial Launch.

2022

EnPlace Gen2 launched

2024

3,000 EnPlace patients to date

Pin It on Pinterest